Investitions-Durchbruch beim Start-up BrainRepair UG - Stammzellenbehandlung für Neugeborene / Dr. Metin Colpan, Gründer von Qiagen N.V. (Nasdaq N.Y.) erwirbt 5% von BrainRepair im Wert von EUR 15 Mio.
mehr
Storys zum Thema Qiagen
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
Lexogen Appoints Stéphane Barges as New CEO
Vienna (ots) - Today Lexogen, the transcriptomics and next-generation sequencing company, announced that Stéphane Barges, PhD, MBA has been appointed as new Chief Executive Officer effective from September 1, 2020. Dr. Barges said "Lexogen is already a renowned company thanks to the quality of its very innovative products and of its customer support provided by dedicated and talented experts. Its technology has been ...
mehr
1